Chase LoPriore

Insider Reports History

Reporting-owner location: Red Bank, NJ
Latest reporting-owner signature: /s/ Chase LoPriore
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Chase LoPriore

Form 4 holding VP, Corp. Dev., Director

Hepion Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 1,250,000
Estimated value: $25,000
Report date: 16 Mar 2026
Price: $0.0200
Ownership: Direct

Form 4 holding VP, Corp. Dev., Director

Hepion Pharmaceuticals, Inc.

Security class: Stock Options
Shares / value: 1,345,500
Estimated value
Report date: 19 Aug 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Chase LoPriore

4 HEPA

Hepion Pharmaceuticals, Inc.

Report period: 19 Aug 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 Aug 2026, 16:33
Role: VP, Corp. Dev., Director
Next action: Open filing details

3 HEPA

Hepion Pharmaceuticals, Inc.

Report period: 16 Mar 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 26 May 2026, 17:00
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .